Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival.

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Abstract Text:

Kottarathil A Abraham,Patrick O'Kelly,Susan Spencer,David P Hickey,Peter J Conlon,J Joseph Walshe,

It is recognized that cytomegalovirus (CMV) infection in transplant recipients may lead to graft loss. Prophylaxis with acyclovir has therefore gained widespread acceptance, but the debate on whether this intervention improves long term graft survival continues. All patients who received renal grafts at the National Renal Transplant Centre, Dublin, between January 1992 and December 1999 were retrospectively analyzed. During this time period, patients who were CMV positive and/or had received grafts from CMV-positive donors were administered prophylactic oral acyclovir 800 mg thrice daily, adjusted for calculated creatinine clearance, from the first day post-transplantation. This treatment was continued for three months unless the graft failed or the patient developed CMV disease or died. Graft and patient outcomes were compared in recipients who received acyclovir with those who did not. Over the study period, 935 patients received renal transplants in our center, of whom 487 were administered acyclovir. The incidence of CMV disease was 3.3 cases per 100 patients per annum in those who required prophylaxis. Despite prophylaxis, graft outcomes were found to be significantly worse (p value < 0.001) in the group that qualified for acyclovir. We conclude that acyclovir provides incomplete protection from the negative impact of CMV on graft survival.

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Publishing Authors By Initials

KA Abraham,P O'Kelly,S Spencer,DP Hickey,PJ Conlon,JJ Walshe,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Renal failure

VOLUME: 30

Page Numbers: 141-6

Journal Abbreviation:

ISSN: 0886-022X

DAY: 26

MONTH: 02

YEAR: 2008

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8701128

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival.

AFFILIATION: Nephrology Directorate, University Hospital Aintree, Liverpool, UK.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Ren Fail

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival Related Publications

• "Sunflower cataract" in Wilson's disease.
• A CASE OF SECONDARY CARCINOMATOUS INFILTRATION OF THE PIA-ARACHNOID OF THE BRAIN, PRESENTING EXCLUSIVELY OCULAR SYMPTOMS DURING LIFE: MENINGITIS CARCINOMATOSA.
• A Phase I Study of the Safety of the Nutritional Supplement, Active Hexose Correlated Compound, AHCC, in Healthy Volunteers.
• A longitudinal study of the yield and clinical utility of a specifically designed secondary hypertension investigation protocol.
• Acrodermatitis enteropathica.
• Benign recurrent intrahepatic "obstructive" jaundice.
• Cause of death in Wilson disease.
• Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience.
• Diagnosis of hysteria.
• Disturbances of aminoacid metabolism following liver injury; a study by means of paper chromatography.
• Effect of cytomegalovirus prophylaxis with acyclovir on renal transplant survival.
• Foetor hepaticus.
• Francis Martin Rouse Walshe, 1885-1973.
• Glutamic acid in hepatic coma.
• Liver and muscle glycogen in normal subjects, in diabetes mellitus and in acute hepatitis; the effects of intravenous adrenaline.
• Liver and muscle glycogen in normal subjects, in diabetes mellitus and in acute hepatitis; under basal conditions.
• Mesangioproliferative glomerulonephritis with IgM deposition: clinical characteristics and outcome.
• Methyl mercaptan in relation to foetor hepaticus.
• Methyl mercaptan in relation to foetor hepaticus.
• Multiple myeloma and renal failure: one center's experience.
• Norwegian scabies.
• Observations on the symptomatology and pathogenesis of hepatic coma.
• On clinical medicine.
• PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE.
• Primary carcinoma of the liver: description of a case with ethanolaminuria, a new and obscure metabolic defect.
• Renal failure associated with alternative medical therapies.
• The HELLP syndrome, a prospective study.
• The action of chelating agents in Wilson's disease.
• The effect of glutamic acid on the coma of hepatic failure.
• Treatment of Wilson's disease with penicillamine.